Biopharma | May 06, 2026
Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
Subscribe To Our Newsletter & Stay Updated
